These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2853732

  • 1. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist.
    Schölkens BA, Linz W, König W.
    J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732
    [Abstract] [Full Text] [Related]

  • 2. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.
    Schölkens BA, Linz W.
    Clin Exp Hypertens A; 1988 Dec; 10(6):1259-70. PubMed ID: 2975971
    [Abstract] [Full Text] [Related]

  • 3. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
    Linz W, Schölkens BA, Kaiser J, Just M, Qi BY, Albus U, Petry P.
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
    [Abstract] [Full Text] [Related]

  • 4. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W, Martorana PA, Schölkens BA.
    J Cardiovasc Pharmacol; 1990 Dec; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
    Linz W, Schölkens BA, Han YF.
    J Cardiovasc Pharmacol; 1986 Dec; 8 Suppl 10():S91-9. PubMed ID: 2438498
    [Abstract] [Full Text] [Related]

  • 6. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
    Schölkens BA, Linz W.
    Klin Wochenschr; 1991 Dec; 69 Suppl 24():1-5. PubMed ID: 1865630
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin.
    Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T.
    Hypertension; 1994 Apr; 23(4):411-8. PubMed ID: 8144208
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment with ramiprilat induces cardioprotection against free radical injury in guinea-pig isolated heart: involvement of bradykinin, protein kinase C and prostaglandins.
    Jin ZQ, Chen X.
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):257-62. PubMed ID: 10779122
    [Abstract] [Full Text] [Related]

  • 9. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
    Linz W, Schölkens BA.
    J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 7():S75-82. PubMed ID: 2485067
    [Abstract] [Full Text] [Related]

  • 10. Bradykinin accounts for improved postischemic function and decreased glutathione release of guinea pig heart treated with the angiotensin-converting enzyme inhibitor ramiprilat.
    Massoudy P, Becker BF, Gerlach E.
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):632-9. PubMed ID: 7516015
    [Abstract] [Full Text] [Related]

  • 11. [Comparisons of effects of Hoe-498 and enalapril in isolated guinea pig hearts and rat myocardium].
    Xiang JZ, Schölkens BA, Linz W, Unger T, Ganten D, Lang RE.
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):96-9. PubMed ID: 3002124
    [No Abstract] [Full Text] [Related]

  • 12. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W, Wiemer G, Schölkens BA.
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [Abstract] [Full Text] [Related]

  • 13. Effects of endothelin on isolated ischaemic rat hearts during ramiprilat, bradykinin and indomethacin perfusion.
    Linz W, Albus U, Schölkens BA.
    J Hypertens Suppl; 1989 Dec; 7(6):S310-1. PubMed ID: 2698945
    [Abstract] [Full Text] [Related]

  • 14. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].
    Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA.
    Z Kardiol; 1994 Dec; 83 Suppl 4():53-6. PubMed ID: 7856280
    [Abstract] [Full Text] [Related]

  • 15. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin.
    Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger T.
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):462-9. PubMed ID: 7528303
    [Abstract] [Full Text] [Related]

  • 16. Influence of the novel non-sulfhydryl converting enzyme-inhibitor, Hoe-498, on isolated rat hearts.
    Xiang JZ, Schölkens BA, Linz W, Unger T.
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):18-20. PubMed ID: 6202091
    [No Abstract] [Full Text] [Related]

  • 17. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC.
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [Abstract] [Full Text] [Related]

  • 18. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
    Nolly H, Miatello R, Damiani MT, Abate CD.
    Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
    [Abstract] [Full Text] [Related]

  • 19. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
    Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J.
    Br J Pharmacol; 1991 Mar; 102(3):769-73. PubMed ID: 1364851
    [Abstract] [Full Text] [Related]

  • 20. Ramiprilat attenuates the local release of noradrenaline in the ischemic myocardium.
    Carlsson L, Abrahamsson T.
    Eur J Pharmacol; 1989 Jul 18; 166(2):157-64. PubMed ID: 2792189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.